SERA LABORATORIES INTERNATIONAL LIMITED
Get an alert when SERA LABORATORIES INTERNATIONAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-06-29 (in 1mo)
Last made up 2025-06-15
Watchouts
Cash
£1M
-9.1% vs 2023
Net assets
£43M
-17.9% vs 2023
Employees
138
-5.5% vs 2023
Profit before tax
-£9M
-79% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
3 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
Net assets
7-year trend · vs Consumer Discretionary median
Accounts
7-year trend · latest reflected 2024-12-31
| Metric | Trend | 2021-01-01 | 2021-12-31 | 2022-01-01 | 2022-12-31 | 2023-01-01 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | £18,286,264 | £17,982,554 | |
| Operating profit | — | — | — | — | — | -£4,321,516 | -£7,401,789 | |
| Profit before tax | — | — | — | — | — | -£5,043,063 | -£9,027,633 | |
| Net profit | — | £2,703,908 | — | £2,933,578 | — | -£5,611,521 | -£9,205,602 | |
| Cash | — | £1,359,579 | — | £813,245 | — | £1,555,785 | £1,413,969 | |
| Total assets less current liabilities | — | £17,270,948 | — | £25,087,763 | — | £73,301,610 | £65,396,189 | |
| Net assets | — | — | — | — | — | £52,836,724 | £43,403,461 | |
| Equity | £8,186,768 | £17,236,763 | £17,236,763 | £25,060,616 | £58,132,849 | £52,836,724 | £43,403,461 | |
| Average employees | — | 32 | — | 36 | — | 146 | 138 | |
| Wages | — | — | — | — | — | £4,323,709 | £4,286,497 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2021-01-01 | 2021-12-31 | 2022-01-01 | 2022-12-31 | 2023-01-01 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | — | -23.6% | -41.2% | |
| Net margin | — | — | — | — | — | -30.7% | -51.2% | |
| Return on capital employed | — | — | — | — | — | -5.9% | -11.3% | |
| Gearing (liabilities / total assets) | — | — | — | — | — | 48.4% | 57.2% | |
| Current ratio | — | — | — | — | — | 1.45x | 1.34x | |
| Interest cover | — | — | — | — | — | -2.43x | -4.21x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Forvis Mazars LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have closely considered the financial position of the Company and the Group. The directors consider that the Group has adequate resources to continue in operation existence for at least twelve months from the date of signing these financial statements following the review of budgets and forecasts which confirm the Groups ability to settle obligations as and when they fall due. The Group is also assured of financial support from Cobalt Holdings I, LP, the ultimate controlling party.”
Group structure
- SERA LABORATORIES INTERNATIONAL LIMITED · parent
- Clinical Trial Laboratory Services Limited 100%
- The Intelligent Tissue Group Limited 100%
- Tissue Solutions Limited 100%
- Cypex Limited 100%
- Fidelis Research EAD 100%
- Fidelis Research RS DOO 100%
- Fidelis Research SRL 100%
- Fidelis Tibbi Arastirma va Gelistirme 100%
- Fidelis Research 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 22 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OGIER GLOBAL (UK) LIMITED | Corporate Secretary | 2024-10-25 | — | — |
| FULLER, Laurie, Ms. | Director | 2023-06-22 | Jun 1966 | American |
| ROMOLI, Andrea | Director | 2023-06-22 | Jan 1974 | American |
| TOBIN, Miguel Bernard | Director | 2016-06-13 | Jul 1985 | British |
Show 22 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BARNETT, Derek | Secretary | 1998-06-01 | 1998-12-01 |
| LEFKOWITZ, Alan | Secretary | 2016-06-13 | 2016-11-16 |
| MURRAY, Jennifer Ann | Secretary | 2014-06-20 | 2014-07-01 |
| MURRAY, Melanie | Secretary | 2000-02-25 | 2014-06-20 |
| SILVERS, Adam | Secretary | 2016-11-16 | 2022-09-29 |
| VADGAMA, Rasik | Secretary | 1998-12-01 | 2000-02-29 |
| HALLMARK SECRETARIES LIMITED | Corporate Nominee Secretary | 1998-06-01 | 1998-06-01 |
| BARNETT, Derek | Director | 1998-06-01 | 1998-12-01 |
| DEIESO, Donald Allan | Director | 2016-06-13 | 2021-10-01 |
| DUNN, Robert Charles | Director | 2014-07-01 | 2016-06-13 |
| FRIEDMAN, Adam | Director | 2021-10-01 | 2026-04-01 |
| GATZ, Jeffrey Mitchell | Director | 2014-07-01 | 2022-09-28 |
| HAIGH, Richard John | Director | 2022-09-28 | 2026-01-28 |
| HOLIDAY III, Harry | Director | 2014-07-01 | 2016-06-13 |
| MCLEAN, Stephen | Director | 2016-06-13 | 2021-10-01 |
| MURRAY, Jennifer Ann | Director | 1998-06-01 | 2014-07-01 |
| MURRAY, Melanie | Director | 2000-02-25 | 2014-06-20 |
| SHUKLA, Piyush Lalit | Director | 2021-10-01 | 2026-04-01 |
| TEMPONE, William | Director | 2016-06-13 | 2023-06-22 |
| VADGAMA, Rasik | Director | 2003-05-01 | 2004-07-01 |
| VADGAMA, Rasik | Director | 1998-12-01 | 2000-02-29 |
| HALLMARK REGISTRARS LIMITED | Corporate Nominee Director | 1998-06-01 | 1998-06-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Bioivt, Llc | Corporate entity | Shares 75–100%, Voting 75–100% | 2021-10-01 | Ceased 2021-10-01 |
| Mr Terrence M. Mullen | Individual | Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2021-10-01 |
| Jeffrey B. Kovach | Individual | Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2021-10-01 |
Filing timeline
Last 20 of 125 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-02 | TM01 | officers | Termination director company with name termination date | |
| 2026-04-02 | TM01 | officers | Termination director company with name termination date | |
| 2026-02-26 | TM01 | officers | Termination director company with name termination date | |
| 2025-12-08 | AA | accounts | Accounts with accounts type group | |
| 2025-12-05 | CH01 | officers | Change person director company with change date | |
| 2025-06-27 | CH01 | officers | Change person director company with change date | |
| 2025-06-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-25 | AA | accounts | Accounts with accounts type group | |
| 2024-10-31 | AP04 | officers | Appoint corporate secretary company with name date | |
| 2024-10-30 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-06-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-02-29 | AA | accounts | Accounts with accounts type group | |
| 2023-11-29 | CH01 | officers | Change person director company with change date | |
| 2023-11-29 | CH01 | officers | Change person director company with change date | |
| 2023-07-21 | AP01 | officers | Appoint person director company with name date | |
| 2023-07-21 | AP01 | officers | Appoint person director company with name date | |
| 2023-07-21 | TM01 | officers | Termination director company with name termination date | |
| 2023-06-21 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-02-06 | AA | accounts | Accounts with accounts type group | |
| 2022-11-04 | SH01 | capital | Capital allotment shares |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 3
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-1.7%
£18,286,264 £17,982,554
-
Cash
-9.1%
£1,555,785 £1,413,969
-
Net assets
-17.9%
£52,836,724 £43,403,461
-
Employees
-5.5%
146 138
-
Operating profit
-71.3%
-£4,321,516 -£7,401,789
-
Profit before tax
-79%
-£5,043,063 -£9,027,633
-
Wages
-0.9%
£4,323,709 £4,286,497
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers